Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
carglumic acid carbamoyl-phosphate synthetase i NA Successful target TTD , DGIDB Hyperammonemia[MeSHID:D022124]
Hyperammonemia
type III[MeSHID:C536109]
Blood[MeSHID:D001769]
Neurotoxicity Syndromes[MeSHID:D020258]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 31.83 approved positive modulator
carglumic acid carbamoyl-phosphate synthase [ammonia], mitochondrial small molecule NA drugbank , DGIDB Hyperammonemia[MeSHID:D022124]
Hyperammonemia
type III[MeSHID:C536109]
Blood[MeSHID:D001769]
Neurotoxicity Syndromes[MeSHID:D020258]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 31.83 approved allosteric modulator,positive modulator
carglumic acid carbamoyl-phosphate synthetase i NA Successful target TTD , DGIDB Hyperammonemia[MeSHID:D022124]
Hyperammonemia
type III[MeSHID:C536109]
Blood[MeSHID:D001769]
Neurotoxicity Syndromes[MeSHID:D020258]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved unknown
carglumic acid carbamoyl-phosphate synthase [ammonia], mitochondrial small molecule NA drugbank , DGIDB Hyperammonemia[MeSHID:D022124]
Hyperammonemia
type III[MeSHID:C536109]
Blood[MeSHID:D001769]
Neurotoxicity Syndromes[MeSHID:D020258]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved allosteric modulator
click here to return to the previous page